Keybanc Maintains Overweight on Progyny, Lowers Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Keybanc has maintained its Overweight rating on Progyny (NASDAQ:PGNY) but has lowered its price target from $45 to $43.

February 28, 2024 | 10:09 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Keybanc maintains an Overweight rating on Progyny but reduces the price target from $45 to $43.
While the maintenance of an Overweight rating suggests continued confidence in Progyny's fundamentals and growth prospects, the reduction in price target could reflect slight adjustments in valuation expectations, possibly due to market conditions or revised earnings forecasts. This mixed signal might lead to short-term price stability as investors digest the implications.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90